Article Text

Download PDFPDF
Portal-systemic shunts, manganese, and parkinsonism
  1. R de la Fuente-Fernández1
  1. 1Division of Neurology, Hospital A Marcide, Estrada San Pedro-Catabois s/n, 15405 Ferrol, A Coruña, Spain
  1. Correspondence to:
 Dr Raúl de la Fuente-Fernández
 rfuentemedynet.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

I read with interest the article by Yoshikawa and colleagues.1 The authors reported the case of a 44 year old woman with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) involving the liver, who had raised serum concentrations of manganese, hyperintense areas in the basal ganglia on T1 weighted magnetic resonance images, and levodopa unresponsive parkinsonism. Naturally, I agree that the parkinsonism in this case is most probably related to portal-systemic (portal-venous) shunts. There are, however, two points that deserve clarification.

First, it is not entirely clear whether their fig 2 (left panel) shows portal-systemic or arteriovenous shunts. The authors say that the figure shows a selective angiogram of the superior mesenteric artery. If that were the case, there should not be a “feeding artery” involved in the intrahepatic shunts (as they state in the legend to fig 2). Instead, the figure would show the portal vein and portal-systemic shunts (that …

View Full Text